ANNUAL COSTS OF BEST SUPPORTIVE CARE FOR PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) IN GERMANY

被引：0
|
作者：
Mathes, J. [1 ]
Kern, B. [1 ]
Kotowa, W. [1 ]
机构：
[1] IGES Inst GmbH, Nurnberg, Germany
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.184
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN101
引用
收藏
页码：A430 / A430
页数：1
相关论文
共 50 条
  • [1] Supportive care in patients with advanced non-small-cell lung cancer
    M Di Maio
    F Perrone
    C Gallo
    R V Iaffaioli
    L Manzione
    F V Piantedosi
    S Cigolari
    A Illiano
    S Barbera
    S F Robbiati
    E Piazza
    G P Ianniello
    L Frontini
    E Veltri
    F Castiglione
    F Rosetti
    E De Maio
    P Maione
    C Gridelli
    British Journal of Cancer, 2003, 89 : 1013 - 1021
  • [2] Supportive care in patients with advanced non-small-cell lung cancer
    Di Maio, M
    Perrone, F
    Gallo, C
    Iaffaioli, RV
    Manzione, L
    Piantedosi, FV
    Cigolari, S
    Illiano, A
    Barbera, S
    Robbiati, SF
    Piazza, E
    Ianniello, GP
    Frontini, L
    Veltri, E
    Castiglione, F
    Rosetti, F
    De Maio, E
    Maione, P
    Gridelli, C
    BRITISH JOURNAL OF CANCER, 2003, 89 (06) : 1013 - 1021
  • [3] The Best Supportive Care in Stage III Non-Small-Cell Lung Cancer
    de Oliveira, Thiago Bueno
    Fontes, Debora Maloni Nasti
    Montella, Tatiane Caldas
    Lewgoy, Jairo
    Dutra, Carolina
    Miola, Thais Manfrinato
    CURRENT ONCOLOGY, 2024, 31 (01) : 183 - 202
  • [4] Supportive care in the era of immunotherapies for advanced non-small-cell lung cancer
    Awada, Gil
    Klastersky, Jean
    CURRENT OPINION IN ONCOLOGY, 2018, 30 (02) : 98 - 104
  • [5] Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer
    Ranson, M
    Davidson, N
    Nicolson, M
    Falk, S
    Carmichael, J
    Lopez, P
    Anderson, H
    Gustafson, N
    Jeynes, A
    Gallant, G
    Washington, T
    Thatcher, N
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (13): : 1074 - 1080
  • [6] Cetuximab in advanced non-small-cell lung cancer (NSCLC)
    Pirker, Robert
    LUNG CANCER, 2012, 77 : S13 - S14
  • [7] A RANDOMIZED TRIAL OF ALTERNATING CHEMOTHERAPY VERSUS BEST SUPPORTIVE CARE IN ADVANCED NON-SMALL-CELL LUNG-CANCER
    CELLERINO, R
    TUMMARELLO, D
    GUIDI, F
    ISIDORI, P
    RASPUGLI, M
    BISCOTTINI, B
    FATATI, G
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (08) : 1453 - 1461
  • [8] Prognostic factor of patients with advanced non-small cell lung cancer receiving best supportive care
    Kishikawa, Takayuki
    Masuda, Shingo
    Oda, Shinya
    Yamaguchi, Keisuke
    Furusato, Yuichiro
    Furusato, Ayaka
    Yamaguchi, Shota
    Inoue, Shigehiro
    Yasaka, Takahiro
    ANNALS OF ONCOLOGY, 2017, 28
  • [9] A retrospective analysis of second-line chemotherapy or best supportive care in patients with advanced-stage non-small-cell lung cancer
    Hatzidaki, Dora
    Agelaki, Sofia
    Mavroudis, Dimitris
    Vlachonikolis, Ioannis
    Alegakis, Athanasios
    Georgoulias, Vassilis
    CLINICAL LUNG CANCER, 2006, 8 (01) : 49 - 55
  • [10] CONTINUATION MAINTENANCE FOR ELDERLY PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC)
    Okamoto, Isamu
    ANNALS OF ONCOLOGY, 2014, 25
12345